These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30804069)

  • 1. Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy.
    Nicoletti T; Spagni G; Luigetti M; Iorio R
    Neurology; 2019 Feb; 92(9):e1000-e1001. PubMed ID: 30804069
    [No Abstract]   [Full Text] [Related]  

  • 2. Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts.
    Tan MB; McAdory LE
    J Radiol Case Rep; 2016 Mar; 10(3):1-10. PubMed ID: 27200161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine-induced Leukoencephalopathy.
    Yoshimura K; Tokunaga S; Daga H; Inoue M
    Intern Med; 2019 Feb; 58(4):621-622. PubMed ID: 30333392
    [No Abstract]   [Full Text] [Related]  

  • 4. Capecitabine-induced acute toxic leukoencephalopathy.
    Obadia M; Leclercq D; Wasserman J; Galanaud D; Dormont D; Sahli-Amor M; Psimaras D; Pyatigorskaya N; Law-Ye B
    Neurotoxicology; 2017 Sep; 62():1-5. PubMed ID: 28487252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permanent lesion to the corticospinal tract after therapy with capecitabine.
    Wagner-Altendorf TA; Heldmann M; Hanssen H; Münte TF
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine leukoencephalopathy.
    Yasiry Z; Obeda MS; Batty R; Sharrack B
    Pract Neurol; 2019 Jun; 19(3):270-271. PubMed ID: 30612099
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine.
    Perrain V; Bihan K; Bompaire F; Houillier C; Jomier F; Leclercq D; Combret S; Mahé J; Ricard D; Berzero G; Psimaras D
    Eur J Neurol; 2021 Jul; 28(7):2396-2402. PubMed ID: 33817933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].
    Shimoyama R; Ban T; Miyake K; Isogai N; Ikegaya Y; Kawachi J; Ogino H; Watanabe K
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1251-3. PubMed ID: 25335709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic analysis of CSF1R-related leukoencephalopathy on magnetic resonance imaging: a case report.
    Huang H; Cao L; Chen H
    BMC Neurol; 2021 Apr; 21(1):156. PubMed ID: 33838643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teaching NeuroImages: 5-FU-induced acute leukoencephalopathy.
    Mehta S; Singh G; Paul BS
    Neurology; 2013 Apr; 80(18):e191. PubMed ID: 23628936
    [No Abstract]   [Full Text] [Related]  

  • 11. [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].
    Yasaki S; Tukamoto Y; Yuasa N; Ishikawa T; Yoshii F
    Rinsho Shinkeigaku; 2012; 52(4):251-6. PubMed ID: 22531658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.
    Acharya G; Cruz Carreras MT; Rice TW
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29167217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine: toxic encephalopathy.
    Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688902
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine related neurotoxicity: Clinical and radiologic features.
    Ong CS; Gao JL; Tan YJ
    J Neurol Sci; 2022 Nov; 442():120444. PubMed ID: 36208584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI findings in methotrexate-induced acute toxic leukoencephalopathy.
    Jakkani RK; Krishna Reddy GV; Anasuri S; Suvarna H; Kumar MS; Satyanarayan S
    Neurol India; 2017; 65(6):1439-1440. PubMed ID: 29133739
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous diffusion-weighted magnetic resonance images and brain blood perfusion scintigraphy for a transient lesion in the splenium of the corpus callosum.
    Nojo T; Takao H; Kohyama J
    Brain Dev; 2008 Mar; 30(3):200-2. PubMed ID: 17720343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.
    Konno T; Yoshida K; Mizuno T; Kawarai T; Tada M; Nozaki H; Ikeda SI; Nishizawa M; Onodera O; Wszolek ZK; Ikeuchi T
    Eur J Neurol; 2017 Jan; 24(1):37-45. PubMed ID: 27680516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI.
    Akitake R; Miyamoto S; Nakamura F; Horimatsu T; Ezoe Y; Muto M; Chiba T
    Jpn J Clin Oncol; 2011 Jan; 41(1):121-4. PubMed ID: 20926409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique radiological case of intrathecal methotrexate-induced toxic leukoencephalopathy.
    Yang J; Kim GS; Park HM
    J Neurol Sci; 2015; 353(1-2):169-71. PubMed ID: 25912173
    [No Abstract]   [Full Text] [Related]  

  • 20. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
    Tsao TF; Chao YH
    Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.